Advances in pretargeting biotechnology

This publication has 64 references indexed in Scilit:

• Experimental Pretargeting Studies of Cancer with a Humanized anti-CEA × Murine anti-[In-DTPA] Bispecific Antibody Construct and a ^99mTc-/¹⁸⁸Re-Labeled Peptide
  Bioconjugate Chemistry, 2000
• Radiation Absorbed Dose Estimation for ⁹⁰Y-DOTA-biotin with Pretargeted NR-LU-10/Streptavidin
  Cancer Biotherapy & Radiopharmaceuticals, 1999
• New Anti-Cu-TETA and Anti-Y-DOTA Monoclonal Antibodies for Potential Use in the Pre-Targeted Delivery of Radiopharmaceuticals to Tumor
  Hybridoma, 1998
• Lungenspeicherung im111In-Octreotid-Szintigramm nach Bestrahlung
  RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 1998
• Evaluation in vitro and in rats of161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy
  European Journal of Nuclear Medicine and Molecular Imaging, 1995
• Development of a bispecific monoclonal antibody against a gallium-67 chelate and the human melanoma-associated antigen p97 for potential use in pretargeted immunoscintigraphy
  Cancer Immunology, Immunotherapy, 1993
• Improved tumor localization with (strept)avidin and labeled biotin as a substitute for antibody
  Nuclear Medicine and Biology, 1993
• Monoclonal antibodies as reversible equilibrium carriers of radiopharmaceuticals
  International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1986
• Monoclonal antibody hapten radiopharmaceutical delivery
  Nuclear Medicine Communications, 1986
• The avidin-biotin complex in immunology
  Immunology Today, 1984